Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1983 May 15;128(10):1158–1160.

Cost without benefit? The introduction of hepatitis B vaccine in Canada.

R A Coates, J G Rankin
PMCID: PMC1875295  PMID: 6404544

Full text

PDF
1158

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanck R. R., Ream N., Conrad M. Hepatitis B antigen and antibody in heroin users. Am J Gastroenterol. 1979 Feb;71(2):164–167. [PubMed] [Google Scholar]
  2. Cederbaum A. I., Blatt P. M., Levine P. H. Abnormal serum transaminase levels in patients with hemophilia A. Arch Intern Med. 1982 Mar;142(3):481–484. [PubMed] [Google Scholar]
  3. Chen D. S., Sung J. L. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol (Stuttg) 1978 Dec;25(6):423–430. [PubMed] [Google Scholar]
  4. Denes A. E., Smith J. L., Maynard J. E., Doto I. L., Berquist K. R., Finkel A. J. Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA. 1978 Jan 16;239(3):210–212. [PubMed] [Google Scholar]
  5. Dienstag J. L., Ryan D. M. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol. 1982 Jan;115(1):26–39. doi: 10.1093/oxfordjournals.aje.a113277. [DOI] [PubMed] [Google Scholar]
  6. Fauci A. S. The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation. Ann Intern Med. 1982 Jun;96(6 Pt 1):777–779. doi: 10.7326/0003-4819-96-6-777. [DOI] [PubMed] [Google Scholar]
  7. Francis D. P., Hadler S. C., Thompson S. E., Maynard J. E., Ostrow D. G., Altman N., Braff E. H., O'Malley P., Hawkins D., Judson F. N. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982 Sep;97(3):362–366. doi: 10.7326/0003-4819-97-3-362. [DOI] [PubMed] [Google Scholar]
  8. Frösner G. G., Buchholz H. M., Gerth H. J. Prevalence of hepatitis B antibody in prostitutes. Am J Epidemiol. 1975 Sep;102(3):241–250. doi: 10.1093/oxfordjournals.aje.a112153. [DOI] [PubMed] [Google Scholar]
  9. Hasiba U. W., Spero J. A., Lewis J. H. Chronic liver dysfunction in multitransfused hemophiliacs. Transfusion. 1977 Sep-Oct;17(5):490–494. doi: 10.1046/j.1537-2995.1977.17578014589.x. [DOI] [PubMed] [Google Scholar]
  10. Hislop W. S., Follett E. A., Bouchier I. A., MacSween R. N. Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol. 1981 Sep;34(9):1017–1019. doi: 10.1136/jcp.34.9.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Islam M. N., Banatvala J. E. The prevalence of hepatitis-B antigen (HB S Ag) and its antibody (Anti-HB S) among London hemophiliacs and blood donors from London and two tropical areas. Transfusion. 1976 May-Jun;16(3):237–241. doi: 10.1046/j.1537-2995.1976.16376225495.x. [DOI] [PubMed] [Google Scholar]
  12. Kim H. C., Saidi P., Ackley A. M., Bringelsen K. A., Gocke D. J. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Gastroenterology. 1980 Dec;79(6):1159–1164. [PubMed] [Google Scholar]
  13. Koplan J. P., Walker J. A., Bryan J. A., Berquist K. R. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis. 1978 Apr;137(4):505–506. doi: 10.1093/infdis/137.4.505. [DOI] [PubMed] [Google Scholar]
  14. Maynard J. E. Nosocomial viral hepatitis. Am J Med. 1981 Feb;70(2):439–444. doi: 10.1016/0002-9343(81)90785-3. [DOI] [PubMed] [Google Scholar]
  15. Mayor G. H., Hourani M. R., Greenbaum D. S., Patterson M. J. Prevalence of hepatitis B in 27 Michigan hemodialysis centers. Am J Public Health. 1979 Jun;69(6):581–584. doi: 10.2105/ajph.69.6.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mulley A. G., Silverstein M. D., Dienstag J. L. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. doi: 10.1056/NEJM198209093071103. [DOI] [PubMed] [Google Scholar]
  17. Pattison C. P., Maynard J. E., Berquist D. R., Webster H. M. Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol. 1975 Jan;101(1):59–64. doi: 10.1093/oxfordjournals.aje.a112071. [DOI] [PubMed] [Google Scholar]
  18. Perrillo R. P., Gelb L., Campbell C., Wellinghoff W., Ellis F. R., Overby L., Aach R. D. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus. Gastroenterology. 1979 Jun;76(6):1319–1325. [PubMed] [Google Scholar]
  19. Schanfield M. S., Scalise G., Economidou I., Modell C. B., Bate C., Zuckerman A. J. Immunogenetic factors in thalassemia and hepatitis B infection. A multicentre study. Dev Biol Stand. 1975;30:257–269. [PubMed] [Google Scholar]
  20. Schweitzer I. L. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci. 1975 Sep-Oct;270(2):287–291. doi: 10.1097/00000441-197509000-00008. [DOI] [PubMed] [Google Scholar]
  21. Sengar D. P., Rashid A., McLeish W. A., Harris J. E., Couture R. A., Sutherland M. Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg. Can Med Assoc J. 1975 Nov 22;113(10):945–948. [PMC free article] [PubMed] [Google Scholar]
  22. Smith J. L., Maynard J. E., Berquist K. R., Doto I. L., Webster H. M., Sheller M. J. From the Center for Disease Control: comparative risk of hepatitis B amono physicians and dentists. J Infect Dis. 1976 Jun;133(6):705–706. doi: 10.1093/infdis/133.6.705. [DOI] [PubMed] [Google Scholar]
  23. Stimmel B., Vernace S., Schaffner F. Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers. JAMA. 1975 Dec 15;234(11):1135–1138. [PubMed] [Google Scholar]
  24. Szmuness W. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols. J Med Virol. 1979;4(4):327–340. doi: 10.1002/jmv.1890040411. [DOI] [PubMed] [Google Scholar]
  25. Szmuness W., Much I., Prince A. M., Hoofnagle J. H., Cherubin C. E., Harley E. J., Block G. H. On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med. 1975 Oct;83(4):489–495. doi: 10.7326/0003-4819-83-4-489. [DOI] [PubMed] [Google Scholar]
  26. Szmuness W., Prince A. M., Grady G. F., Mann M. K., Levine R. W., Friedman E. A., Jacobs M. J., Josephson A., Ribot S., Shapiro F. L. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA. 1974 Feb 25;227(8):901–906. doi: 10.1001/jama.227.8.901. [DOI] [PubMed] [Google Scholar]
  27. Szmuness W., Prince A. M., Hirsch R. L., Brotman B. Familial clustering of hepatitis B infection. N Engl J Med. 1973 Nov 29;289(22):1162–1166. doi: 10.1056/NEJM197311292892203. [DOI] [PubMed] [Google Scholar]
  28. Tabor E., Gerety R. J., Mott M., Wilbur J. Prevalence of hepatitis B in a high-risk setting: a serologic study of patients and staff in a pediatric oncology unit. Pediatrics. 1978 May;61(5):711–715. [PubMed] [Google Scholar]
  29. Wong D. C., Purcell R. H., Rosen L. Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. Am J Epidemiol. 1979 Sep;110(3):227–236. doi: 10.1093/oxfordjournals.aje.a112807. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES